Thank you for visiting the Promixin Support website, a website which was intended for patients prescribed Promixin (colistimethate sodium) by a healthcare professional.
We regret to inform you that Proximin has been discontinued. We apologise for any disruption caused.
Although this website is no longer available, the I-nhale support programme will continue until December 2025 for existing patients that have been enrolled.
If you require medical advice or have any questions about your treatment, please speak with your healthcare professional.
Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine. Side effects should also be reported to Zambon UK Limited on +44(0) 800 0288 942 or by email to drugsafetyUK@zambongroup.com.
UK-PRO-RES-2500001
May 2025